Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0000940805-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | F - Tax | $297.88 | -3,084 | 441.5K | -0.7% | -$918.7K |
| D | 2025-09-03 | 2025-09-01 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | +6,353 | 444.6K | +1% | $0 |
| DM | 2025-09-03 | 2025-09-01 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | -6,353 | 2,082 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-09-01 | F | D | 3,084 | $297.88 | 441,507 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2025-09-01 | M | A | 6,353 | $0.00 | 444,591 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 1,266 | $0.00 | 0 | D | $0.00 · — to — | 1,266 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 4 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 3,005 | $0.00 | 6,010 | D | $0.00 · — to — | 3,005 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 5 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 2,082 | $0.00 | 2,082 | D | $0.00 · — to — | 2,082 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |